Skip to content

Solute carrier family 2, facilitated glucose transporter member 8 (SLC2A8)

Homo sapiens — UniProt Q9NY64

Gene: SLC2A8Homo sapiensSwissProt reviewedTransporter

Data last refreshed: (UniProt release unknown)

Key facts

Solute carrier family 2, facilitated glucose transporter member 8 (SLC2A8) is a protein from Homo sapiens identified by UniProt accession Q9NY64, 477 residues long. MolForge cross-references it against 0 known binders and 107 disease associations.

  • UniProt accession: Q9NY64; gene symbol SLC2A8.
  • Organism: Homo sapiens.
  • Length: 477 amino acids.
  • Target class: Transporter.
  • Top disease associations (Open Targets): neurodegenerative disease, glioblastoma multiforme and cognitive decline measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameSolute carrier family 2, facilitated glucose transporter member 8
UniProt accessionQ9NY64
GeneSLC2A8
OrganismHomo sapiens
Length477 residues
Molecular weight—
EC numbers—
Target classTransporter (inferred from UniProt keywords / EC)
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (107)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.34
  • glioblastoma multiforme · score 0.23
  • cognitive decline measurement · score 0.21
  • lung adenocarcinoma · score 0.18
  • azoospermia · score 0.07
  • male infertility with teratozoospermia due to single gene mutation · score 0.06
  • platelet count · score 0.05
  • familial sick sinus syndrome · score 0.05
  • Brugada syndrome · score 0.05
  • spermatogenic failure 7 · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9NY64-F1alphafoldPREDICTED85.37—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9NY64.

Amino-acid sequence (477 residues)

MTPEDPEETQ PLLGPPGGSA PRGRRVFLAA FAAALGPLSF GFALGYSSPA IPSLQRAAPP APRLDDAAAS WFGAVVTLGA AAGGVLGGWL VDRAGRKLSL LLCSVPFVAG FAVITAAQDV WMLLGGRLLT GLACGVASLV APVYISEIAY PAVRGLLGSC VQLMVVVGIL LAYLAGWVLE WRWLAVLGCV PPSLMLLLMC FMPETPRFLL TQHRRQEAMA ALRFLWGSEQ GWEDPPIGAE QSFHLALLRQ PGIYKPFIIG VSLMAFQQLS GVNAVMFYAE TIFEEAKFKD SSLASVVVGV IQVLFTAVAA LIMDRAGRRL LLVLSGVVMV FSTSAFGAYF KLTQGGPGNS SHVAISAPVS AQPVDASVGL AWLAVGSMCL FIAGFAVGWG PIPWLLMSEI FPLHVKGVAT GICVLTNWLM AFLVTKEFSS LMEVLRPYGA FWLASAFCIF SVLFTLFCVP ETKGKTLEQI TAHFEGR

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with SLC2A8?

The strongest Open Targets associations for SLC2A8 are neurodegenerative disease, glioblastoma multiforme, cognitive decline measurement, lung adenocarcinoma and azoospermia.

How long is the SLC2A8 protein?

The Homo sapiens SLC2A8 protein (UniProt Q9NY64) is 477 amino acids long.

Browse: Targets: S · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Solute carrier family 2, facilitated glucose transporter member 8 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9NY64
GeneSLC2A8
OrganismHomo sapiens
Length477
Binders0
Diseases107
View on UniProt